Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
More than a month after Mylan and Pfizer reported to Health Canada that there are new issues affecting some EpiPens, the companies and the FDA notified U.S. healthcare providers of the problem which can delay treatment when the pens are needed. Mylan, Pfizer and the FDA Friday reported that some pens and their authorized generic… Read More »